A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication, years before such evidence became public. 2010/2/22 |
Centers for Disease Control (CDC) announced yesterday that they will include a five-in-one vaccination for children in the regular vaccination plans for infants to replace the three-in-one vaccination and the oral poliovirus vaccine. 2010/2/8 , 1 Comment |
![]() | The Consumers' Foundation (CF) announced yesterday that most cold syrups being sold on local markets do not have sufficient instructions and warning statements on the label. 2010/1/29 |
Tests of the first two oral drugs developed for treating multiple sclerosis show that both cut the frequency of relapses and may slow progression of the disease, but with side effects that could pose a tough decision for patients. 2010/1/26 |
Strong warnings about the dangers of giving antipsychotic drugs to patients with dementia have reduced use of the drugs in these patients by a “modest” 19 percent, U.S. researchers said on Monday. 2010/1/13 |
Scientists may have created a vaccine against cocaine addiction: a series of shots that changes the body's chemistry so that the drug can't enter the brain and provide a high. 2010/1/6 |
![]() | The Far Eastern Memorial Hospital in Taipei County yesterday published 10 'must-knows' that many people are unaware of when taking medication. 2009/12/24 |
Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain. 2009/12/14 |
About 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said on Tuesday. 2009/12/10 |
ChemGenex Pharmaceuticals Ltd., an unprofitable Australian drugmaker, said its experimental leukemia drug cleared the disease in 86 percent of patients, confirming results under review by U.S. and European regulators. 2009/12/7 |




